Editor’s Choice: Survivor Status and Orphan Status are Both Good Signs in the Rare Disease World

Happy Friday! This week, we have a story that might break your heart about a woman who battled cystic fibrosis. But we also have a story that might inspire you about a…

Continue Reading Editor’s Choice: Survivor Status and Orphan Status are Both Good Signs in the Rare Disease World
New Study of Trigeminal Neuralgia (TN) Often Preceding a MS Diagnosis
[Source: pixabay.com]

New Study of Trigeminal Neuralgia (TN) Often Preceding a MS Diagnosis

Trigeminal neuralgia (TN), or extreme, sudden facial pain associated with the 5th cranial nerve, occurs frequently in patients who have received a multiple sclerosis (MS) diagnosis. In a survey with 8,590 respondents,…

Continue Reading New Study of Trigeminal Neuralgia (TN) Often Preceding a MS Diagnosis
Finally! Sjogren’s Syndrome has its First Official Treatment Guidelines
Source: pixabay

Finally! Sjogren’s Syndrome has its First Official Treatment Guidelines

According to Dr. Steven Carson, of all the autoimmune disorders that are both chronic and joint-related, Sjogren's syndrome remains the hardest to manage. Standards of care designed to guide doctors…

Continue Reading Finally! Sjogren’s Syndrome has its First Official Treatment Guidelines
2017 is Proving a Big Year for Orphan Drug Designation: Here’s Another One!
Source: pixabay.com

2017 is Proving a Big Year for Orphan Drug Designation: Here’s Another One!

In recent news in the oncology community, the FDA has approved orphan drug designation to a new drug, SurVaxM, for glioblastoma. Glioblastoma is a rare type of brain cancer that…

Continue Reading 2017 is Proving a Big Year for Orphan Drug Designation: Here’s Another One!
Close Menu